Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 5 | 2011 | 36 | 1.190 |
Why?
|
| Heart-Assist Devices | 4 | 2011 | 16 | 1.130 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 129 | 1.050 |
Why?
|
| Coronary Artery Disease | 4 | 2023 | 126 | 0.960 |
Why?
|
| Stents | 5 | 2010 | 80 | 0.940 |
Why?
|
| Coronary Stenosis | 4 | 2006 | 16 | 0.810 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2010 | 4 | 0.700 |
Why?
|
| Pulmonary Embolism | 4 | 2008 | 55 | 0.670 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 22 | 0.650 |
Why?
|
| Thrombectomy | 3 | 2008 | 30 | 0.620 |
Why?
|
| Cardiac Catheterization | 4 | 2017 | 61 | 0.600 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2023 | 24 | 0.590 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2023 | 20 | 0.590 |
Why?
|
| Heart Transplantation | 3 | 2010 | 29 | 0.580 |
Why?
|
| Coronary Angiography | 9 | 2023 | 67 | 0.570 |
Why?
|
| Aortic Valve | 4 | 2023 | 25 | 0.550 |
Why?
|
| Coronary Vessels | 3 | 2017 | 33 | 0.550 |
Why?
|
| Thrombosis | 2 | 2022 | 48 | 0.540 |
Why?
|
| Aneurysm, False | 2 | 2007 | 7 | 0.510 |
Why?
|
| Diastole | 4 | 2010 | 27 | 0.480 |
Why?
|
| Heart Failure | 2 | 2022 | 166 | 0.470 |
Why?
|
| Treatment Outcome | 15 | 2023 | 3231 | 0.440 |
Why?
|
| Humans | 36 | 2023 | 25692 | 0.430 |
Why?
|
| Subclavian Artery | 2 | 2010 | 3 | 0.410 |
Why?
|
| Drug-Eluting Stents | 2 | 2022 | 15 | 0.380 |
Why?
|
| Aorta | 1 | 2011 | 15 | 0.370 |
Why?
|
| Fibrinolytic Agents | 2 | 2011 | 53 | 0.370 |
Why?
|
| Calcinosis | 2 | 2010 | 48 | 0.360 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 2 | 2007 | 4 | 0.360 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 28 | 0.360 |
Why?
|
| Foreign-Body Migration | 2 | 2008 | 18 | 0.360 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 120 | 0.360 |
Why?
|
| Pericardium | 1 | 2010 | 18 | 0.350 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 13 | 0.350 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 4 | 0.350 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 6 | 0.340 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 2 | 0.340 |
Why?
|
| Artifacts | 2 | 2009 | 31 | 0.340 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 10 | 0.340 |
Why?
|
| Angioplasty | 1 | 2010 | 6 | 0.340 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2010 | 4 | 0.340 |
Why?
|
| Balloon Occlusion | 2 | 2007 | 8 | 0.340 |
Why?
|
| Hepatic Veins | 1 | 2010 | 9 | 0.340 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 5 | 0.340 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 26 | 0.340 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 21 | 0.330 |
Why?
|
| Heart Diseases | 1 | 2010 | 60 | 0.330 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 1 | 0.290 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2007 | 10 | 0.290 |
Why?
|
| Vascular Surgical Procedures | 1 | 2007 | 24 | 0.290 |
Why?
|
| Mammary Arteries | 1 | 2007 | 4 | 0.290 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2023 | 9 | 0.280 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 7 | 0.280 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 48 | 0.280 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 27 | 0.280 |
Why?
|
| Transducers, Pressure | 1 | 2006 | 4 | 0.260 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 2 | 0.260 |
Why?
|
| Male | 18 | 2021 | 13917 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2010 | 698 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2010 | 827 | 0.230 |
Why?
|
| Heart Aneurysm | 1 | 2004 | 8 | 0.220 |
Why?
|
| Hypotension | 1 | 2022 | 23 | 0.210 |
Why?
|
| Female | 13 | 2021 | 14273 | 0.210 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2022 | 39 | 0.200 |
Why?
|
| Adult | 9 | 2017 | 7336 | 0.190 |
Why?
|
| Middle Aged | 10 | 2011 | 8403 | 0.180 |
Why?
|
| Conservative Treatment | 1 | 2021 | 19 | 0.180 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 23 | 0.180 |
Why?
|
| Aged | 10 | 2021 | 8501 | 0.170 |
Why?
|
| Hemodynamics | 2 | 2010 | 57 | 0.170 |
Why?
|
| Catheterization | 3 | 2010 | 39 | 0.170 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 20 | 0.170 |
Why?
|
| Health Resources | 1 | 2019 | 23 | 0.170 |
Why?
|
| Network Meta-Analysis | 3 | 2023 | 32 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2021 | 618 | 0.150 |
Why?
|
| Constriction, Pathologic | 3 | 2010 | 31 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2007 | 1689 | 0.150 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2007 | 35 | 0.150 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 3 | 0.150 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.150 |
Why?
|
| Incidental Findings | 1 | 2017 | 13 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 10 | 0.140 |
Why?
|
| Risk Factors | 5 | 2023 | 2224 | 0.140 |
Why?
|
| Phlebography | 3 | 2017 | 9 | 0.140 |
Why?
|
| Atrial Appendage | 1 | 2017 | 29 | 0.140 |
Why?
|
| Punctures | 2 | 2010 | 9 | 0.140 |
Why?
|
| Exercise Test | 1 | 2017 | 103 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2022 | 75 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 4459 | 0.130 |
Why?
|
| Saphenous Vein | 2 | 2007 | 4 | 0.120 |
Why?
|
| Heart Ventricles | 2 | 2008 | 96 | 0.120 |
Why?
|
| Aortic Rupture | 2 | 2003 | 5 | 0.110 |
Why?
|
| Sinus of Valsalva | 2 | 2003 | 4 | 0.110 |
Why?
|
| Aortic Aneurysm | 2 | 2003 | 14 | 0.110 |
Why?
|
| Death | 2 | 2023 | 35 | 0.110 |
Why?
|
| Bayes Theorem | 2 | 2023 | 39 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2013 | 46 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 913 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 10 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 13 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 26 | 0.090 |
Why?
|
| Echocardiography | 2 | 2008 | 88 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2011 | 38 | 0.090 |
Why?
|
| Peptides | 1 | 2011 | 104 | 0.090 |
Why?
|
| Prosthesis Design | 2 | 2009 | 447 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2010 | 3 | 0.090 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 10 | 0.080 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2010 | 73 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 340 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 281 | 0.080 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2008 | 2 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2009 | 255 | 0.080 |
Why?
|
| Vena Cava Filters | 1 | 2008 | 8 | 0.070 |
Why?
|
| Gastrectomy | 1 | 2008 | 26 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2007 | 25 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 9 | 0.070 |
Why?
|
| Angiography | 1 | 2007 | 29 | 0.070 |
Why?
|
| Chest Pain | 1 | 2007 | 18 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2007 | 101 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2006 | 2 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2006 | 8 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 17 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2006 | 45 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 67 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 217 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2019 | 131 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 19 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2004 | 51 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 15 | 0.050 |
Why?
|
| Child | 1 | 2007 | 1277 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 21 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Neprilysin | 1 | 2022 | 11 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 8 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 21 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2002 | 6 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 68 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2022 | 49 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 66 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 48 | 0.050 |
Why?
|
| Health Status | 1 | 2023 | 209 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 163 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 136 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 311 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2019 | 59 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 600 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 136 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 132 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 329 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 403 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 300 | 0.040 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 9 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 341 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1336 | 0.030 |
Why?
|
| Device Removal | 2 | 2008 | 85 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 3220 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1943 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 68 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 457 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 87 | 0.020 |
Why?
|
| Computer Systems | 1 | 2006 | 7 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 209 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 472 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 646 | 0.010 |
Why?
|
| Prolapse | 1 | 2003 | 1 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 26 | 0.010 |
Why?
|
| Aortography | 1 | 2003 | 5 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2002 | 3 | 0.010 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2002 | 3 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2002 | 10 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2002 | 10 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 30 | 0.010 |
Why?
|